What Orthoxel does

OrthoXel is a privately held Irish medical device company founded in 2014 and headquartered in Cork, Ireland, that develops and commercializes orthopaedic trauma fracture fixation devices. Its core product platform consists of the Apex Nailing System family (tibial, femoral antegrade, and femoral retrograde intramedullary nails) and the Vertex Hip Fracture Nailing System, all built around proprietary controlled axial micromotion technology designed to promote secondary bone healing while maintaining torsional stability — a mechanism positioned as first-in-class for intramedullary nails. The Vertex Hip Fracture Nailing System received FDA 510(k) clearance in 2024 and is not currently available for sale in the European Union.

The company sells exclusively through a network of medical device distributors serving hospitals and orthopaedic trauma surgeons globally, with direct operations in Ireland and the United States. Its clinical evidence base is anchored by named collaborations with leading US academic medical centers (UC Davis Medical Center, Brigham and Women's Hospital, Baylor College of Medicine), Cork University Hospital in Ireland, and an academic research partnership with Lehigh University's Department of Mechanical Engineering and Mechanics. Leadership is concentrated among surgeon-founders (Chief Medical Officer James Harty, a Professor of Orthopaedic Surgery at University College Cork) and biomechanics researchers (Chief Scientific Officer Hannah Dailey, Associate Professor at Lehigh University), supported by CEO and co-founder Pat O'Connor and Chief Technical Officer and co-founder Charles Daly.

OrthoXel generates revenue through hardware sales of its nailing systems via third-party distributor channels; pricing is not publicly disclosed and is determined through distributor relationships and hospital procurement processes. The disclosed capital base consists of an Enterprise Ireland funding round in 2016, with no institutional venture capital, private equity, or strategic corporate investors identified in available data. The company's value proposition centers on faster fracture healing, reduced nonunion risk, and clinical efficacy in challenging cases (non-weightbearing, delayed-healing, senescent bone, complex flap and transport procedures), supported by published white papers on micromotion fixation outcomes.

Name

Orthoxel

Legal name

OrthoXel

Website

https://orthoxel.net

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

OrthoXel is a Cork, Ireland-based medical device company that develops and commercializes intramedullary nailing systems (Apex and Vertex HFN families) for orthopaedic trauma fracture fixation, using proprietary controlled axial micromotion technology and selling globally through medical device distributors to hospitals and surgeons.

Ownership category

akta.pro rank

Product category

Orthopaedic Trauma Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industry

Orthopedic Trauma (HLAKALAD)

Keywords

• Orthopaedic trauma devices
• Intramedullary nailing systems
• Fracture fixation implants
• Orthopaedic medical devices
• Bone healing technology

Headquarters

HQ city

Cork

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: OrthoXel generates revenue through the sale of orthopaedic trauma fixation devices including the Apex tibial, femoral antegrade, and femoral retrograde nailing systems, as well as the Vertex Hip Fracture Nailing System. Products are sold to hospitals and orthopaedic trauma surgeons through distributor networks.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

OrthoXel develops, manufactures, and sells intramedullary nailing systems for orthopaedic trauma fracture fixation. Its core product portfolio includes the Apex Tibial, Apex Femoral Antegrade, Apex Femoral Retrograde, and Vertex Hip Fracture Nailing Systems, all built on proprietary controlled axial micromotion technology designed to promote secondary bone healing while maintaining torsional stability. Products are sold to hospitals and orthopaedic trauma surgeons globally through medical device distributors.

Product overview

OrthoXel is a medical device company developing and launching a fracture fixation portfolio of orthopaedic trauma devices. The core product line consists of the Apex Nailing System family (including Tibial, Femoral Antegrade, and Femoral Retrograde variants) and the Vertex Hip Fracture Nailing System. All Apex products utilize proprietary Micromotion Technology to promote secondary bone healing with controlled axial micromotion while maintaining torsional stability. The Vertex HFN received FDA 510(k) clearance and is not currently available for sale in the EU.

Differentiator

Problem solved

Functional benefit

Brands

• Apex: Apex Tibial Nailing System and Apex Femoral Nailing Systems featuring micromotion technology for fracture fixation
• Vertex
• Micromotion Technology

Products and services

• Apex Tibial Nailing System Intramedullary nailing system for tibial fractures that promotes secondary bone healing with controlled axial micromotion and outstanding torsional stability, allowing mini-dynamization even with multiple interlocks. Targeted at orthopaedic trauma surgeons and hospitals treating complex tibial fractures, non-weightbearing and delayed-healing cases.
• Apex Femoral Antegrade Nailing System Femoral nailing system using an antegrade approach that extends the Apex micromotion technology to femoral fractures. Designed for orthopaedic trauma surgeons and hospitals managing femoral fracture fixation.
• Apex Femoral Retrograde Nailing System Femoral nailing system using a retrograde approach that delivers controlled micromotion for fracture healing. Indicated for orthopaedic trauma surgeons and hospitals performing retrograde femoral nailing procedures.
• Vertex Hip Fracture Nailing System (Vertex HFN) Hip fracture nailing system providing optimal stability, versatility and usability through a fluted nail stem, two interdigitating screws, and a stability-focused set screw, enabling tailored treatment for individual patient and fracture needs. FDA 510(k) cleared. Targeted at orthopaedic trauma surgeons and hospitals treating hip fractures, including geriatric trauma patients.

Quantifiable outcome

• Stimulates robust callus formation even in senescent bone
• +1 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• UC Davis Medical CentercoreStrategic or Co-development PartnerClinical collaboration with orthopaedic trauma surgeons Sean Campbell and Augustine Saiz who have conducted clinical studies and provided testimonials on the Apex Nailing System. Surgeons have used the system in complex cases including flap and transport procedures.
• Brigham and Women's HospitalcoreStrategic or Co-development PartnerClinical partnership including live surgical demonstration of the Apex Tibial Nailing System at The Summit in Cologne, Germany. Surgeons Michael J. Weaver and Arvind Von Keudell have participated in demonstrations and provided clinical insights.
• Baylor College of MedicinecoreStrategic or Co-development PartnerClinical partnership with Professor Douglas R. Dirschl who has provided commentary on FDA 510(k) clearance of the Vertex Hip Fracture Nailing System and anticipates clinical use.
• Lehigh UniversitycoreStrategic or Co-development PartnerAcademic research partnership with Associate Professor of Mechanical Engineering & Mechanics Hannah Dailey who serves as Chief Scientific Officer. Provides biomechanics research and technology development expertise.
• Cork University HospitalcoreStrategic or Co-development PartnerClinical partnership with Professor James Harty who serves as Chief Medical Officer and Consultant Orthopaedic Surgeon. Contributes clinical expertise to product development.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Stryker: One of the largest orthopedic implant manufacturers globally, with established IM nailing systems (e.g., T2, Gamma, VariAx) that directly compete with OrthoXel's Apex and Vertex franchises in hospitals and trauma centers worldwide.
• DePuy Synthes (Johnson & Johnson): Johnson & Johnson's orthopedic franchise and a clear market leader in intramedullary nailing (Expert, ETN, Tibial Nail systems) with a deep trauma sales force and the most entrenched hospital contracts OrthoXel must displace.
• Smith & Nephew: Major orthopedic medical device player with the TRIGEN and IM nail portfolio for tibial, femoral and hip fractures, competing head-to-head with OrthoXel in surgeon mindshare and hospital procurement cycles.
• Zimmer Biomet: Global orthopedic trauma and reconstruction leader with Natural Nail and Affixus IM nailing systems, presenting an incumbent alternative OrthoXel must displace in trauma operating rooms.
• Orthofix Medical: Orthopedic device company with a focus on trauma and extremity fixation; smaller than Stryker or J&J but an established niche competitor in the same surgeon customer base OrthoXel targets with Apex and Vertex.
• CONMED: Mid-sized orthopedic and sports medicine device company with a trauma fixation portfolio including IM nails, operating with a direct sales and distributor model similar in shape to OrthoXel's approach.

Emerging players

• Acumed: Specialty orthopedic trauma and extremity implant manufacturer with innovation-driven products, comparable in scale to OrthoXel and competing for the same surgeon-driven adoption among fracture fixation specialists.
• Conventus Orthopaedics: Earlier-stage orthopedic trauma innovator focused on novel fracture fixation technologies, relevant as a peer in bringing differentiated implant approaches to the same orthopedic trauma surgeon community.
• Tyber Medical: Privately held orthopedic trauma and spine device company with a private-label and niche IM nail offering, comparable in size and commercialization stage to OrthoXel and competing for similar hospital accounts.

Others

• Bioventus: Orthopedic-focused medtech company with an adjacent trauma and bone-healing portfolio (including biologics used in fracture care), relevant as a thematic peer addressing the same bone healing and orthopedic trauma markets from a different modality.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/orthoxel

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orthoxel